| Jennifer Marie Tareco, MD | |
|
766 Route 202/206, Suite 1, Bridgewater, NJ 08807-1777 | |
| (908) 722-0808 | |
| (908) 722-7645 |
| Full Name | Jennifer Marie Tareco |
|---|---|
| Gender | Female |
| Speciality | Orthopaedic Surgery - Pediatric Orthopaedic Surgery |
| Location | 766 Route 202/206, Bridgewater, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184626327 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XP3100X | Orthopaedic Surgery - Pediatric Orthopaedic Surgery | 25MA06690400 (New Jersey) | Primary |
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
inSleep Health announced today that it has received 510(K) clearance for the company's Cloud9 Anti-Snoring System. The indication for use is to reduce or eliminate simple snoring in adults. Cloud9 is a prescription device for home use. This is the first clinically proven device, using continuous low positive airway pressure, specifically labeled to treat simple snoring.
The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks.
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
Australian regenerative medicine company, Mesoblast Limited, today announced that the Australian Therapeutic Goods Administration (TGA) has issued a licence to Mesoblast to manufacture and supply its proprietary Mesenchymal Precursor Cell (MPC) products.
› Verified 2 days ago
| Entity Name | Robert Wood Johnson Physician Enterprise |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245587922 PECOS PAC ID: 5597917633 Enrollment ID: O20121218000345 |
News Archive
inSleep Health announced today that it has received 510(K) clearance for the company's Cloud9 Anti-Snoring System. The indication for use is to reduce or eliminate simple snoring in adults. Cloud9 is a prescription device for home use. This is the first clinically proven device, using continuous low positive airway pressure, specifically labeled to treat simple snoring.
The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks.
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
Australian regenerative medicine company, Mesoblast Limited, today announced that the Australian Therapeutic Goods Administration (TGA) has issued a licence to Mesoblast to manufacture and supply its proprietary Mesenchymal Precursor Cell (MPC) products.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Marie Tareco, MD 766 Route 202/206, Suite 1, Bridgewater, NJ 08807-1777 Ph: (908) 722-0808 | Jennifer Marie Tareco, MD 766 Route 202/206, Suite 1, Bridgewater, NJ 08807-1777 Ph: (908) 722-0808 |
News Archive
inSleep Health announced today that it has received 510(K) clearance for the company's Cloud9 Anti-Snoring System. The indication for use is to reduce or eliminate simple snoring in adults. Cloud9 is a prescription device for home use. This is the first clinically proven device, using continuous low positive airway pressure, specifically labeled to treat simple snoring.
The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks.
Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.
On the day of the opening ceremonies of the XVII International AIDS Conference in Mexico City, President Felipe Calderon announced his plans to lift a Mexican Ministry of Economy requirement that pharmaceutical companies operating in Mexico must have a manufacturing plant in that country in order to use or sell generic versions of their lifesaving AIDS and other drugs in Mexico.
Australian regenerative medicine company, Mesoblast Limited, today announced that the Australian Therapeutic Goods Administration (TGA) has issued a licence to Mesoblast to manufacture and supply its proprietary Mesenchymal Precursor Cell (MPC) products.
› Verified 2 days ago
Dr. Kimberly Victoria Tucker, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 720 Us Highway 202/206, Bridgewater, NJ 08807 Phone: 908-722-2033 Fax: 908-707-8344 | |
Mr. Sharmez Gresshel Savoy, PA-C Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1200 Route 22 Ste 14, Bridgewater, NJ 08807 Phone: 973-376-6595 | |
Harlan Edward Hiramoto, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 465 Union Ave, Suite C, Bridgewater, NJ 08807 Phone: 908-429-7600 Fax: 908-429-7960 | |
Dr. David A. Abrutyn, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 215 Union Ave, Suite B, Bridgewater, NJ 08807 Phone: 908-685-8500 Fax: 908-685-8009 | |
Dr. Paul J. Hirsch, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 720 Us Highway 202/206, Bridgewater, NJ 08807 Phone: 908-722-2033 Fax: 908-707-8344 | |
Dr. Vineet Tyagi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1125 Us Highway 22 Ste 150, Bridgewater, NJ 08807 Phone: 908-722-2033 |